Network meta-analysis of medical therapy efficacy in more than 90,000 patients with heart failure and reduced ejection fraction.
Vincenzo De MarzoGianluigi SavareseLucia TricaricoSofia HassanMassimo IacovielloItalo PortoPietro AmeriPublished in: Journal of internal medicine (2022)
Combination medical therapy including neurohormonal inhibitors and newer drugs, especially ARNI and SGLT2i, confers the maximum benefit with regard to HFrEF prognosis.